Page 13 - HFA Dateline 2019-2020 Special Issue

T:8.5"
S:7"

GO SEEK. GO EXPLORE. B:8.75" PEOPLE LIKE YOU. STORIES LIKE YOURS.

Explore more at HEMLIBRAjourney.com
GO AHEAD.

Discover your sense of go. Discover HEMLIBRA. S:9.5" T:11" B:11.25"
®

What is HEMLIBRA?
HEMLIBRA is a prescription medicine used for routine prophylaxis to prevent or reduce the frequency of bleeding
episodes in adults and children, ages newborn and older, with hemophilia A with or without factor VIII inhibitors.
What is the most important information I should know about HEMLIBRA?

HEMLIBRA increases the potential for your blood to clot. Carefully follow your healthcare provider’s
instructions regarding when to use an on-demand bypassing agent or factor VIII, and the dose and
schedule to use for breakthrough bleed treatment. HEMLIBRA may cause serious side effects when used
®
with activated prothrombin complex concentrate (aPCC; FEIBA ), including thrombotic microangiopathy
®
(TMA), and blood clots (thrombotic events). If aPCC (FEIBA ) is needed, talk to your healthcare provider in
®
case you feel you need more than 100 U/kg of aPCC (FEIBA ) total.
Please see Brief Summary of Medication Guide on following page for Important Safety
Information, including Serious Side Effects.